NeRRe Therapeutics
Steve Pawsey joined NeRRe Therapeutics as Chief Medical Officer in January 2017. An anaesthetist by training, Steve has extensive experience in the global pharmaceutical and biotechnology sectors, having worked in a broad range of development and medical positions in a career approaching 30 years.
NeRRe Therapeutics
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.